Scientists are one step closer to developing a treatment for a genetic enzyme deficiency that can cause red blood cells to break down in response to infections or certain drugs or foods, like fava beans. In extreme cases, reactions can be fatal. The research, led by Stanford’s Daria Mochly-Rosen, PhD, and Sunhee Hwang, PhD, identified a small […]Continue Reading ...
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier–which keeps large molecules in the blood from entering the brain–becomes abnormally permeable, allowing fibrin to leak into the brain and trigger inflammation. Emerging evidence points to a leaky blood-brain barrier as an early event in brain diseases […]Continue Reading ...
The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types. ID CORE XT is the second molecular assay approved for use in transfusion medicine, […]Continue Reading ...
X. Long Zheng. Credit: UAB In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. The researchers deliver this therapeutic enzyme via the cellular equivalent of a Trojan Horse, using tiny blood cell platelets as their protective delivery vehicle, with a key […]Continue Reading ...
For those patients with atrial fibrillation (AFib) at high risk of having a stroke, drugs that reduce the blood’s ability to clot are quite effective. In most cases, these blood thinners effectively eliminate the risk of having a type of stroke that frequently occurs with this heart condition. At the same time, excessive bleeding is […]Continue Reading ...
Engineers at UC San Diego used wearable off-the-shelf technology and machine learning to predict, for the first time, an individual’s blood pressure and provide personalized recommendations to lower it based on this data. Their work earned the title of Best Paper at IEEE Healthcom 2018. To the researchers’ knowledge, this is the first work investigating […]Continue Reading ...
In my clinical practice, I’ve found that patients with the irregular heart rhythm atrial fibrillation (AFib) do the best when they contribute to their own care by: Learning the difference between AFib and a normal heart rhythm. Eating a heart-healthy diet that slows down underlying problems linked to AFib. Gaining knowledge about AFib medications and […]Continue Reading ...
The Johns Hopkins Hospital blood bank is always ready to activate a mass transfusion protocol for patients who need large amounts of blood. Credit: Johns Hopkins Medicine In a new analysis of data submitted to Maryland’s state trauma registry from 2005 to 2017, Johns Hopkins Medicine researchers found that gunshot victims are approximately five times […]Continue Reading ...
Oct 12 2018 In Animal Study, CHOP Hematologist Restores Blood Cell Function in Fanconi Anemia Pediatric researchers studying the life-threatening blood disorder Fanconi anemia (FA) have devised a method to block the abnormal biological signals that drive the disease. This proof-of-concept finding in animals and stem cells from human cord blood may lay the foundation […]Continue Reading ...
Oct 12 2018 A new nationally agreed standard of care released today (Thursday) aims to reduce the tens of thousands of Australian lives put at risk each year by largely preventable blood clots, which kill four times more people than road accidents. Each year 30,000 Australians develop blood clots – known as venous thromboembolism (VTE) […]Continue Reading ...
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma. Researchers from the University of Missouri School of Medicine and the Massachusetts Institute of Technology recently evaluated the accuracy of an MIT-developed technology to monitor blood glucose levels without needles or a finger […]Continue Reading ...
The largest ever genetic analysis of over one million people has identified 535 new genes associated with high blood pressure. The international team included Professor Jo Knight of Lancaster Medical School who is Chair in Applied Data Science. The researchers concluded : “The combined effect of all associated variants shows a large aggregated risk, warranting […]Continue Reading ...
Credit: CC0 Public Domain Over 500 new gene regions that influence people’s blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London. Involving more than one million participants, the results more than triple the number of blood pressure […]Continue Reading ...
According to a new study, frequent fluctuations in body weight, cholesterol, blood sugar and blood pressure can have a catastrophic effect on heart health and life expectancy. In the study, sudden changes in metabolic health parameters were associated with a raised risk of heart attacks, strokes and even early deaths. Image Credit: karen roach / […]Continue Reading ...
PORTLAND, Ore., Sept. 26, 2018 /PRNewswire/ — Aronora Inc., a clinical stage biotechnology company developing first-in-class treatments for life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for proCase (E-WE thrombin, AB002), an enzyme that is intended to reverse blood clot formation without increasing the risk of […]Continue Reading ...
- Application of blood pressure guidelines ups treatment
- Stanford researchers find that small molecule may help treat enzyme deficiency
- Speed Cameras Save Money and Lives in New York City
- Men who conform to ‘the man box’ more likely to consider suicide and violence
- Researchers aim to create more authentic organoids for drug testing, transplantation
- New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies
- Age-related estrogen increase may be the culprit behind inguinal hernias in men
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- Researchers uncover new role of TIP60 protein in controlling tumour formation
- Behind the scenes of a lifesaving heart surgery
- ‘To See the Suffering’
- Drinking concentrated rosemary extract can boost memory by up to 15%, shows research
- Medicare Advantage riding high as new insurers flock to sell to seniors
- NHS tackles prescription fraud to save millions
- New molecular switch may help develop sophisticated photomedications
- Health Highlights: Oct. 12, 2018
- Study holds promise for new pediatric brain tumor treatment
- Patient advocate uses MRI scans to create art and spark conversations about life with illness
- Fish oil based diets may suppress growth and spread of breast cancer cells
- Number of VHA facilities offering acupuncture has increased rapidly